Castle Biosciences Q1 2025 10-Q Filed
Ticker: CSTL · Form: 10-Q · Filed: 2025-05-05T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, reporting
TL;DR
Castle Biosciences Q1 2025 10-Q is in. Financials and biz updates out.
AI Summary
Castle Biosciences Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in the medical diagnostics sector.
Why It Matters
This filing provides investors with the latest financial snapshot of Castle Biosciences, crucial for understanding the company's performance and outlook in the medical diagnostics market.
Risk Assessment
Risk Level: medium — 10-Q filings are standard financial reports, but the specific financial health and market position of Castle Biosciences could introduce medium risk.
Key Players & Entities
- Castle Biosciences Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250505 (date) — Filing date
- 001-38984 (other) — SEC File Number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 5, 2025.
What is the company's SEC File Number?
The company's SEC File Number is 001-38984.
What is the fiscal year end for Castle Biosciences Inc.?
The fiscal year end for Castle Biosciences Inc. is December 31.
What is the business address of Castle Biosciences Inc.?
The business address is 505 S FRIENDSWOOD DRIVE, SUITE 401, FRIENDSWOOD, TX 77546.
From the Filing
0001447362-25-000069.txt : 20250505 0001447362-25-000069.hdr.sgml : 20250505 20250505161032 ACCESSION NUMBER: 0001447362-25-000069 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250505 DATE AS OF CHANGE: 20250505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC CENTRAL INDEX KEY: 0001447362 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 770701774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38984 FILM NUMBER: 25913031 BUSINESS ADDRESS: STREET 1: 505 S FRIENDSWOOD DRIVE STREET 2: SUITE 401 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 BUSINESS PHONE: 866-788-9007 MAIL ADDRESS: STREET 1: 505 S FRIENDSWOOD DRIVE STREET 2: SUITE 401 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 10-Q 1 cstl-20250331.htm 10-Q cstl-20250331 0001447362 12/31 2025 Q1 false P5Y 1 1 1 1 481 139 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure cstl:segment cstl:reporting_unit 0001447362 2025-01-01 2025-03-31 0001447362 2025-04-24 0001447362 2025-03-31 0001447362 2024-12-31 0001447362 2024-01-01 2024-03-31 0001447362 us-gaap:CommonStockMember 2023-12-31 0001447362 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001447362 us-gaap:RetainedEarningsMember 2023-12-31 0001447362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001447362 2023-12-31 0001447362 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001447362 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001447362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001447362 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001447362 us-gaap:CommonStockMember 2024-03-31 0001447362 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001447362 us-gaap:RetainedEarningsMember 2024-03-31 0001447362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001447362 2024-03-31 0001447362 us-gaap:CommonStockMember 2024-12-31 0001447362 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001447362 us-gaap:RetainedEarningsMember 2024-12-31 0001447362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001447362 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001447362 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001447362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001447362 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001447362 us-gaap:CommonStockMember 2025-03-31 0001447362 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001447362 us-gaap:RetainedEarningsMember 2025-03-31 0001447362 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001447362 srt:MinimumMember 2025-03-31 0001447362 srt:MaximumMember 2025-03-31 0001447362 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0001447362 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001447362 cstl:DermatologicMember 2025-01-01 2025-03-31 0001447362 cstl:DermatologicMember 2024-01-01 2024-03-31 0001447362 cstl:NonDermatologicMember 2025-01-01 2025-03-31 0001447362 cstl:NonDermatologicMember 2024-01-01 2024-03-31 0001447362 cstl:ThirdPartyPayorConcentrationRiskMember cstl:MedicareMember us-gaap:RevenueFromContractWithCustomerMember 2025-01-01 2025-03-31 0001447362 cstl:ThirdPartyPayorConcentrationRiskMember cstl:MedicareMember us-gaap:RevenueFromContractWithCustomerMember 2024-01-01 2024-03-31 0001447362 cstl:ThirdPartyPayorConcentrationRiskMember cstl:MedicareMember cstl:AccountsReceivableCurrentMember 2025-01-01 2025-03-31 0001447362 cstl:ThirdPartyPayorConcentrationRiskMember cstl:MedicareMember cstl:AccountsReceivableCurrentMember 2024-01-01 2024-12-31 0001447362 cstl:ThirdPartyPayorConcentrationRiskMember cstl:PayorAMember us-gaap:RevenueFromContractWithCustomerMember 2025-01-01 2025-03-31 0001447362 cstl:ThirdPartyPayorConcentrationRiskMember cstl:PayorAMember us-gaap:R